766 results on '"Hagberg, Lars"'
Search Results
2. Mapping the World Health Organization Disability Assessment Schedule (WHODAS 2.0) onto SF-6D Using Swedish General Population Data
3. The Cost-Effectiveness of a Dance and Yoga Intervention for Girls with Functional Abdominal Pain Disorders
4. Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression
5. Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance.
6. IgG and kappa free light chain CSF/serum indices: evaluating intrathecal immunoglobulin production in HIV infection in comparison with multiple sclerosis
7. CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection
8. Adolescent depression, early psychiatric comorbidities, and adulthood welfare burden: a 25-year longitudinal cohort study
9. Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
10. Osteomyelitis Risk in Patients With Transfemoral Amputations Treated With Osseointegration Prostheses
11. No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau)
12. Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy
13. Cost-effectiveness of an indicated preventive intervention for depression in adolescents: a model to support decision making
14. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
15. Depressive disorders in adolescence, recurrence in early adulthood, and healthcare usage in mid-adulthood: A longitudinal cost-of-illness study
16. Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection.
17. Increased immune activation and signs of neuronal injury in HIV-negative people on preexposure prophylaxis
18. An Example of Genetically Distinct HIV Type 1 Variants in Cerebrospinal Fluid and Plasma During Suppressive Therapy
19. Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients
20. Cerebrospinal Fluid (CSF) Neuronal Biomarkers across the Spectrum of HIV Infection: Hierarchy of Injury and Detection
21. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.
22. Approach to Cerebrospinal Fluid (CSF) Biomarker Discovery and Evaluation in HIV Infection
23. CSF biomarkers in patients with COVID-19 and neurological symptoms: A case series
24. Cerebrospinal Fluid and Neuroimaging Biomarker Abnormalities Suggest Early Neurological Injury in a Subset of Individuals During Primary HIV Infection
25. Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy
26. Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections
27. Factors associated with blood culture positivity in patients with complicated skin and skin structure infection—a population-based study
28. CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series
29. Osseointegrated Titanium Implants for Limb Prostheses Attachments: Infectious Complications
30. Cerebrospinal Fluid Neopterin: An Informative Biomarker of Central Nervous System Immune Activation in HIV-1 Infection
31. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection
32. Cohort profile: a longitudinal study of HIV infection in the central nervous system with focus on cerebrospinal fluid – the Gothenburg HIV CSF Study Cohort
33. Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study
34. Motivation to uphold physical activity in women with breast cancer during adjuvant chemotherapy treatment
35. Long-term physical activity on prescription intervention for patients with insufficient physical activity level—a randomized controlled trial
36. What is the time cost of exercise? Cost of time spent on exercise in a primary health care intervention to increase physical activity
37. Cost-effectiveness and quality of life of a diet intervention postpartum: 2-year results from a randomized controlled trial
38. Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection
39. Cost-Effectiveness of Prolonged Physical Activity on Prescription in Previously Non-Complying Patients: Impact of Physical Activity Mediators
40. Residual Central Nervous System Immune Activation Is Not Prevented by Antiretroviral Therapy Initiated During Early Chronic HIV Infection
41. On the Reacitivty of 2-Methylene-3-quinuclidinone in Water
42. Which patients benefit from physical activity on prescription (PAP)? A prospective observational analysis of factors that predict increased physical activity
43. Cost-effectiveness of antibiotic prophylaxis in elective cesarean section
44. Digitally distributed Yoga Intervention in Breast Cancer Rehabilitation (DigiYoga CaRe): protocol for a randomised controlled trial
45. The effects of a 5-year physical activity on prescription (PAP) intervention in patients with metabolic risk factors
46. The effect of vitamin B supplementation on neuronal injury in people living with HIV: a randomized controlled trial
47. We Propose a Novel Measure for Social Welfare and Public Health: Capability-Adjusted Life-Years, CALYs
48. Neurochemical Evidence of Potential Neurotoxicity After Prophylactic Cranial Irradiation
49. Integrative medicine for back and neck pain: Exploring cost-effectiveness alongside a randomized clinical pilot trial
50. Cerebrospinal fluid biomarkers in cardiac arrest survivors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.